These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6018366)

  • 41. Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid.
    Zullo A; Rinaldi V; Hassan C; Folino S; Winn S; Pinto G; Attili AF
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):405-9. PubMed ID: 9789138
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of high-volume plasmapheresis on ammonia, urea, and amino acids in patients with acute liver failure.
    Clemmesen JO; Kondrup J; Nielsen LB; Larsen FS; Ott P
    Am J Gastroenterol; 2001 Apr; 96(4):1217-23. PubMed ID: 11316173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Several factors in the pathogenesis of hepatic failure in patients with liver cirrhosis and bleeding from esophageal and gastric varicose veins].
    Bour AV; Manuk'ian GV; Umruzakov IU; Shertsinger AG
    Anesteziol Reanimatol; 1993; (2):32-4. PubMed ID: 7943876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis.
    Liu Q; Duan ZP; Ha DK; Bengmark S; Kurtovic J; Riordan SM
    Hepatology; 2004 May; 39(5):1441-9. PubMed ID: 15122774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
    Fabbri A; Marchesini G; Bianchi G; Bugianesi E; Bortoluzzi L; Zoli M; Pisi E
    Hepatology; 1993 Jul; 18(1):28-35. PubMed ID: 8325618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pathogenesis of portal systemic encephalopathy].
    García Compeán D; Valadez Castillo R; Barragán RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():113-9. PubMed ID: 19256149
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.
    Hanada S; Kumashiro R; Kaji R; Harada M; Sata M
    Int J Mol Med; 2002 Nov; 10(5):647-8. PubMed ID: 12373309
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Rationale for the use of sodium benzoate in clinical hepatology].
    Poo JL; Cervera E; de Hoyos A; Gil S; Cadena M; Uribe M
    Rev Invest Clin; 1990 Jul; 42 Suppl():101-5. PubMed ID: 19256146
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Breath and blood ammonia in liver cirrhosis.
    Shimamoto C; Hirata I; Katsu K
    Hepatogastroenterology; 2000; 47(32):443-5. PubMed ID: 10791209
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gastric urease activity in normal subjects and in subjects with cirrhosis.
    RAPPOPORT WJ; KERN F
    J Lab Clin Med; 1963 Apr; 61():550-9. PubMed ID: 13973136
    [No Abstract]   [Full Text] [Related]  

  • 52. SOME EFFECTS OF INDUCTION OF UREASE IMMUNITY IN PATIENTS WITH HEPATIC INSUFFICIENCY.
    THOMSON A; VISEK WJ
    Am J Med; 1963 Dec; 35():804-12. PubMed ID: 14089297
    [No Abstract]   [Full Text] [Related]  

  • 53. Brain histology and behavior of mice injected with urease.
    Gibson GE; Zimber A; Krook L; Richardson EP; Visek WJ
    J Neuropathol Exp Neurol; 1974 Apr; 33(2):201-11. PubMed ID: 4822569
    [No Abstract]   [Full Text] [Related]  

  • 54. Diet and hepatic encephalopathy.
    Lancet; 1983 Mar; 1(8325):625-6. PubMed ID: 6131304
    [No Abstract]   [Full Text] [Related]  

  • 55. Impaired ammonia metabolism in severe hepatic disease.
    Lechi C; Lechi A; Lo Cascio V
    Clin Chim Acta; 1969 Apr; 24(1):181-2. PubMed ID: 5780160
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunological control of endogenous urease activity in buffalo calves.
    Sahota RS; Jethi RK
    Zentralbl Veterinarmed A; 1981; 28(3):247-51. PubMed ID: 6792835
    [No Abstract]   [Full Text] [Related]  

  • 57. [New strategies for the damaged liver].
    Stiefelhagen P
    MMW Fortschr Med; 2007 Feb; 149(7):10-2, 14. PubMed ID: 17612224
    [No Abstract]   [Full Text] [Related]  

  • 58. [The investigation of protein tolerance in cases of liver cirrhosis by means of protein loading test using different proteins].
    Gürakar M; Dölle W; Strohmeyer G
    Turk Tip Cemiy Mecm; 1966 Feb; 32(2):109-16. PubMed ID: 5947968
    [No Abstract]   [Full Text] [Related]  

  • 59. Live E. coli cells to treat uremia.
    Wrong O
    Nat Med; 1997 Jan; 3(1):3; author reply 3-4. PubMed ID: 8986726
    [No Abstract]   [Full Text] [Related]  

  • 60. Urea degradation with hollow fiber bound urease and ammonium-ion removal with macrocyclic polyethers.
    Rawer P; Krausch D; Schütterle G
    Contrib Nephrol; 1982; 32():186-91. PubMed ID: 7128157
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.